2022 2021 2020 2019 Cognition Therapeutics Provides Update on Corporate and Pipeline Progress and Reviews Goals for 2022 Jan 10, 2022 Read More » Cognition Therapeutics Receives Grant from Michael J. Fox Foundation to Support Development of Sigma-2 Receptor Modulator for Parkinson’s Disease Jan 04, 2022 Read More »
Cognition Therapeutics Provides Update on Corporate and Pipeline Progress and Reviews Goals for 2022 Jan 10, 2022 Read More »
Cognition Therapeutics Receives Grant from Michael J. Fox Foundation to Support Development of Sigma-2 Receptor Modulator for Parkinson’s Disease Jan 04, 2022 Read More »
